Era Systems

Era is a biotechnology company focused on developing a new class of RNA-based medicines through its proprietary RNA editing and delivery platform. The company aims to overcome the limitations of traditional gene editing by utilizing programmable RNA technologies that allow for precise, reversible, and non-permanent modifications to genetic expression. Era's approach focuses on treating a wide range of diseases by modulating RNA function without the risks associated with permanent DNA alterations. The company is currently in the pre-clinical stage, advancing its platform to target various therapeutic areas including rare diseases and oncology.